Skip to main content
. 2016 Apr 28;42(5):608–617. doi: 10.1097/DSS.0000000000000755

TABLE 2.

Treatment-emergent adverse events With Incidence ≥2% in Any Treatment Group During Treatment Period (Safety Population)

graphic file with name ds-42-608-g007.jpg